这些常见化疗药的禁忌症,你都弄清楚了吗?

2022-08-25 MedSci原创 MedSci原创

临床用药一定注意这些禁忌症!

​化疗药物是临床应用比较广泛的抗肿瘤药物,具有独特的分子结构及作用机制,临床应用时往往存在诸多的注意事项。同时,为了达到最佳的抗肿瘤效果,临床上常常采用多种化疗药物联合用药的治疗方案,因而容易出现药物之间的配伍禁忌。合理的用药不仅无法达到治疗期望,还可能出现“增毒减效”的效果。

为此,小编特地整理了常见化疗药物的禁忌症以供各位读者参考学习

常见化疗药物的禁忌症

参考文献:

[1] 张小娟, 白卉, 郑莹,等. 临床化疗药物配伍禁忌[J]. 护理研究:中旬版, 2017, 31(006):2070-2072.

[2] 冯爽. 临床化疗药物配伍禁忌分析[J]. 临床医药文献电子杂志, 2018, 5(20):2.

[3] 金冶宁, 王雅杰. 肿瘤化疗药物应用中的配伍与禁忌[J]. 中国实用内科杂志, 1996, 015(006):478-479.

[4] 药品说明书.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1466750, encodeId=eedb1466e50ee, content=<a href='/topic/show?id=67f3e463637' target=_blank style='color:#2F92EE;'>#禁忌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74636, encryptionId=67f3e463637, topicName=禁忌症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06006859456, createdName=xlxchina, createdTime=Fri Aug 26 09:31:03 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545134, encodeId=af421545134eb, content=<a href='/topic/show?id=b7abe4635e0' target=_blank style='color:#2F92EE;'>#禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74635, encryptionId=b7abe4635e0, topicName=禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Aug 26 09:31:03 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581788, encodeId=120f1581e8870, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33579, encryptionId=0813335e996, topicName=化疗药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=298f16872689, createdName=12498cb5m18暂无昵称, createdTime=Fri Aug 26 09:31:03 CST 2022, time=2022-08-26, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1466750, encodeId=eedb1466e50ee, content=<a href='/topic/show?id=67f3e463637' target=_blank style='color:#2F92EE;'>#禁忌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74636, encryptionId=67f3e463637, topicName=禁忌症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06006859456, createdName=xlxchina, createdTime=Fri Aug 26 09:31:03 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545134, encodeId=af421545134eb, content=<a href='/topic/show?id=b7abe4635e0' target=_blank style='color:#2F92EE;'>#禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74635, encryptionId=b7abe4635e0, topicName=禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Aug 26 09:31:03 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581788, encodeId=120f1581e8870, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33579, encryptionId=0813335e996, topicName=化疗药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=298f16872689, createdName=12498cb5m18暂无昵称, createdTime=Fri Aug 26 09:31:03 CST 2022, time=2022-08-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1466750, encodeId=eedb1466e50ee, content=<a href='/topic/show?id=67f3e463637' target=_blank style='color:#2F92EE;'>#禁忌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74636, encryptionId=67f3e463637, topicName=禁忌症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06006859456, createdName=xlxchina, createdTime=Fri Aug 26 09:31:03 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545134, encodeId=af421545134eb, content=<a href='/topic/show?id=b7abe4635e0' target=_blank style='color:#2F92EE;'>#禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74635, encryptionId=b7abe4635e0, topicName=禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Aug 26 09:31:03 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581788, encodeId=120f1581e8870, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33579, encryptionId=0813335e996, topicName=化疗药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=298f16872689, createdName=12498cb5m18暂无昵称, createdTime=Fri Aug 26 09:31:03 CST 2022, time=2022-08-26, status=1, ipAttribution=)]